Hypoglycaemia is associated with increased risk of fractures in patients with type 2 diabetes mellitus: a cohort study.

Objective Type 2 diabetes is associated with an increased risk of fracture. Any factor that incrementally increases this risk should be taken into account when individualising treatment. Hypoglycaemia is a common complication of antidiabetes medications and suggested as a risk factor for fractures; yet, its real-life clinical impact is unclear. Design A population-based, retrospective open cohort study using routinely collected data between 1st of January 1995 and 1st of May 2016 in The Health Improvement Network (THIN) database. Methods Patients with type 2 diabetes mellitus with documented hypoglycaemic events were compared to randomly matched patients with type 2 diabetes mellitus without documented hypoglycaemic events matched to exposed patients on age, sex, duration of diabetes and BMI. The primary outcome was any incident fracture. Secondary outcome was incident fragility (osteoporotic) fracture. Results A total of 41 163 patients with type 2 diabetes were included: 14 147 patients in the exposed cohort and 27 016 patients in the unexposed cohort. Patients with a documented hypoglycaemic event were significantly more likely to sustain any fracture compared to patients with no record of hypoglycaemic events: adjusted IRR = 1.20 (95% CI: 1.12-1.30; P < 0.0001). Patients who had a documented hypoglycaemic event were significantly more likely to suffer a fragility fracture compared to controls: adjusted IRR = 1.24 (95% CI: 1.13-1.37; P < 0.0001). Conclusions Hypoglycaemic events are a significant risk factor for fractures in patients with diabetes mellitus. This observation is clinically relevant when individualising targets for glycaemic control and selecting antidiabetic agents.

[1]  A. Nakamura,et al.  Commentary: Short Body Height and Pre-pregnancy Overweight for Increased Risk of Gestational Diabetes Mellitus: A Population-Based Cohort Study , 2018, Front. Endocrinol..

[2]  W. Liu,et al.  Risk of low-energy fracture in type 2 diabetes patients: a meta-analysis of observational studies , 2017, Osteoporosis International.

[3]  M. Javaid,et al.  Costs of fragility hip fractures globally: a systematic review and meta-regression analysis , 2017, Osteoporosis International.

[4]  A. Díez-Pérez,et al.  Insulin use and Excess Fracture Risk in Patients with Type 2 Diabetes: A Propensity-Matched cohort analysis , 2017, Scientific Reports.

[5]  G. Schernthaner,et al.  Prevalence, glucose control and relative survival of people with Type 2 diabetes in the UK from 1991 to 2013 , 2017, Diabetic medicine : a journal of the British Diabetic Association.

[6]  K. Toulis,et al.  All-cause mortality in patients with diabetes under glucagon-like peptide-1 agonists: A population-based, open cohort study. , 2017, Diabetes & metabolism.

[7]  P. Singh.  A STUDY OF LIFESTYLE INTERVENTIONS IN PATIENTS WITH TYPE2 DIABETES MELLITUS , 2017 .

[8]  K. Toulis,et al.  All-Cause Mortality in Patients With Diabetes Under Treatment With Dapagliflozin: A Population-Based, Open-Cohort Study in The Health Improvement Network Database , 2017, The Journal of clinical endocrinology and metabolism.

[9]  Y. Hung,et al.  Severe hypoglycemia and hip fracture in patients with type 2 diabetes: a nationwide population-based cohort study , 2017, Osteoporosis International.

[10]  P. Vestergaard,et al.  Epidemiology of Fractures in Diabetes , 2017, Calcified Tissue International.

[11]  M. Vavlukis.  Are diabetes mellitus and lipoprotein(a) independently or causally associated with an increased cardiovascular risk? , 2016, Anatolian journal of cardiology.

[12]  K. Toulis,et al.  Type 1 diabetes mellitus and risk of incident epilepsy: a population-based, open-cohort study , 2016, Diabetologia.

[13]  C. Fischbacher,et al.  Trends in type 2 diabetes incidence and mortality in Scotland between 2004 and 2013 , 2016, Diabetologia.

[14]  Y. Loke,et al.  Meta-analysis: Association between hypoglycaemia and serious adverse events in older patients. , 2016, Journal of diabetes and its complications.

[15]  D. Kendrick,et al.  Epidemiology of poisonings, fractures and burns among 0-24 year olds in England using linked health and mortality data. , 2016, European journal of public health.

[16]  Hyunah Kim,et al.  The effect of sitagliptin on cardiovascular risk profile in Korean patients with type 2 diabetes mellitus: a retrospective cohort study , 2016, Therapeutics and clinical risk management.

[17]  M. Britton,et al.  Hypoglycaemia in elderly patients with type 2 diabetes mellitus: a review of risk factors, consequences and prevention , 2015 .

[18]  U. Iloeje,et al.  Association between hypoglycemia and fall-related events in type 2 diabetes mellitus: analysis of a U.S. commercial database. , 2015, Journal of managed care & specialty pharmacy.

[19]  J. Roy,et al.  Use of demographic and pharmacy data to identify patients included within both the Clinical Practice Research Datalink (CPRD) and The Health Improvement Network (THIN) , 2015, Pharmacoepidemiology and drug safety.

[20]  K. Lapane,et al.  Sulfonylurea Use and Risk of Hip Fractures Among Elderly Men and Women with Type 2 Diabetes , 2015, Drugs & Aging.

[21]  A. Maguire,et al.  A retrospective database study of insulin initiation in patients with Type 2 diabetes in UK primary care , 2012, Diabetic medicine : a journal of the British Diabetic Association.

[22]  C. Conner,et al.  Association between hypoglycaemic events and fall‐related fractures in Medicare‐covered patients with type 2 diabetes , 2012, Diabetes, obesity & metabolism.

[23]  E. Vittinghoff,et al.  Intensive Glycemic Control Is Not Associated With Fractures or Falls in the ACCORD Randomized Trial , 2012, Diabetes Care.

[24]  B. Al-Ghurabi,et al.  A comparative Study on Serum Leptin and Adiponectin levels in Periodontitis Patients with and without Diabetes Mellitus Type2 , 2012 .

[25]  K. F. Moseley.  Type 2 diabetes and bone fractures , 2012, Current opinion in endocrinology, diabetes, and obesity.

[26]  A. Bourke,et al.  Generalisability of The Health Improvement Network (THIN) database: demographics, chronic disease prevalence and mortality rates. , 2011, Informatics in primary care.

[27]  T. Sugimoto,et al.  Low Serum Level of the Endogenous Secretory Receptor for Advanced Glycation End Products (esRAGE) Is a Risk Factor for Prevalent Vertebral Fractures Independent of Bone Mineral Density in Patients With Type 2 Diabetes , 2009, Diabetes Care.

[28]  J. Cauley,et al.  Bone Mass and Strength in Older Men With Type 2 Diabetes: The Osteoporotic Fractures in Men Study , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[29]  A. Maguire,et al.  The importance of defining periods of complete mortality reporting for research using automated data from primary care , 2009, Pharmacoepidemiology and drug safety.

[30]  J. Mindell,et al.  The epidemiology of fractures in England , 2008, Journal of Epidemiology & Community Health.

[31]  D. Balzi,et al.  Bone Fractures and Hypoglycemic Treatment in Type 2 Diabetic Patients , 2007, Diabetes Care.

[32]  C. Sachon,et al.  Identification of factors associated with impaired hypoglycaemia awareness in patients with type 1 and type 2 diabetes mellitus. , 2005, Diabetes & metabolism.

[33]  P. Vestergaard,et al.  Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk , 2005, Diabetologia.

[34]  S. Bridgman,et al.  Epidemiology of femoral fractures in children in the West Midlands region of England 1991 to 2001. , 2004, The Journal of bone and joint surgery. British volume.

[35]  A. Schwartz.  Epidemiology of fractures in type 2 diabetes. , 2016, Bone.

[36]  T. Alsaadawi.  Smoking is Associated with Increased Risk ofOsteoporosis in Diabetes Mellitus Patients , 2016 .

[37]  N. Booth.  What are the Read Codes? , 1994, Health libraries review.